Literature DB >> 22933863

Improved understanding of risk factors could help to reduce the incidence of hepatocellular carcinoma.

Myron J Tong1.   

Abstract

Entities:  

Year:  2012        PMID: 22933863      PMCID: PMC3424427     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


× No keyword cloud information.
  3 in total

1.  Statin use and the risk of liver cancer: a population-based case–control study.

Authors:  Hui-Fen Chiu; Shu-Chen Ho; Chih-Cheng Chen; Chun-Yuh Yang
Journal:  Am J Gastroenterol       Date:  2010-12-14       Impact factor: 10.864

2.  Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.

Authors:  Yu-Tse Tsan; Chang-Hsing Lee; Jung-Der Wang; Pau-Chung Chen
Journal:  J Clin Oncol       Date:  2012-01-23       Impact factor: 44.544

3.  Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes.

Authors:  Hashem B El-Serag; Michael L Johnson; Christine Hachem; Robert O Morgana
Journal:  Gastroenterology       Date:  2009-01-30       Impact factor: 22.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.